对醒脑静联合依达拉奉治疗重症脑梗死的临床疗效展开研究

Study on the Clinical Effect of Xingnaojing Combined with Edaravone in the Treatment of Severe Cerebral Infarction

目的:分析醒脑静联合依达拉奉治疗重症脑梗死的临床疗效。方法:对某院2016年6月~2019年6月收治的40例患者按挂号先后顺序均分为参照组和观察组各20例。参照组用醒脑静治疗,观察组用醒脑静联合依达拉奉治疗,比较两组的治疗效果和神经功能缺失评分。结果:治疗后参照组治疗效果明显低于观察组,有统计学意义(P<0.05);治疗后参照组神经功能缺失评分明显低于观察组,有统计学意义(P<0.05)。结论:对醒脑静联合依达拉奉治疗重症脑梗死的临床疗效展开研究情况良好,醒脑静联合依达拉奉治疗重症脑梗死提高了患者治疗后的康复情况,保护了患者脑部的神经功能,值得在临床上进一步推广。

Objective:To analyze the clinical effect of Xingnaojing combined with Edaravone in the treatment of severe cerebral infarction.Methods:From June 2016 to June 2019,40 patients were divided into reference group(n=20)and observation group(n=20).The control group was treated with Xingnaojing and the observation group was treated with Xingnaojing combined with edaravone.The therapeutic effect and neurological deficit score were compared between the two groups.Results:After treatment,the treatment effect of the reference group was significantly lower than that of the observation group(P<0.05);After the treatment,the neurological deficit score of the reference group was significantly lower than that of the observation group(P<0.05).Conclusion:The clinical effect of Xingnaojing combined with edaravone in the treatment of severe cerebral infarction is very good.Xingnaojing combined with edaravone in the treatment of severe cerebral infarction can improvess the rehabilitation of patients after treatment,and protect the neurological function of the brain of patients,which is worthy of popularizing in clinic.